Equasens (FRA:PHF) EV-to-FCF: (As of Jul. 02, 2026)


FRA:PHF Equasens FRA:PHF
93 GF Score
Price €52.77
GF Value €85.23
! 2 Warning Signs
View Full Analysis

What is Equasens EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Equasens's Enterprise Value is €497.1 Mil. Equasens's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil. Therefore, Equasens's EV-to-FCF for today is .

The historical rank and industry rank for Equasens's EV-to-FCF or its related term are showing as below:

FRA:PHF' s EV-to-FCF Range Over the Past 10 Years
Min: 10.67   Med: 31.09   Max: 69.37
Current: 10.89

During the past 13 years, the highest EV-to-FCF of Equasens was 69.37. The lowest was 10.67. And the median was 31.09.

FRA:PHF's EV-to-FCF is ranked better than
66.5% of 406 companies
in the Healthcare Providers & Services industry
Industry Median: 17.57 vs FRA:PHF: 10.89

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-02), Equasens's stock price is €52.77. Equasens's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €2.590. Therefore, Equasens's PE Ratio (TTM) for today is 20.37.


Equasens  (FRA:PHF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Equasens's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=52.77/2.590
=20.37

Equasens's share price for today is €52.77.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Equasens's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €2.590.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Equasens EV-to-FCF Related Terms


Equasens EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Equasens's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Equasens EV-to-FCF Chart

Equasens Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.48 24.14 21.78 19.01 14.01

Equasens Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.78 0.00 19.01 0.00 14.01

FRA:PHF vs VEEV, BTSG, TEM: EV-to-FCF Comparison

For the Health Information Services subindustry, Equasens's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Equasens EV-to-FCF vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Equasens's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Equasens's EV-to-FCF falls into.


FRA:PHF
93GF Score
Equasens FRA:PHF
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Equasens EV-to-FCF Calculation

Equasens's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=497.132/0
=

Equasens's current Enterprise Value is €497.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Equasens's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Equasens (FRA:PHF) Overvalued in 2026?

Based on GuruFocus' analysis, Equasens stock appears to be undervalued. The current stock price of €52.77 is trading 38.1% below its estimated GF Value™ of €85.23.

Key valuation signals for FRA:PHF:

  • EV-to-FCF:
  • GF Value™: €85.23 vs. price of €52.77 (38.1% below fair value)
  • GF Score™: 93/100 with 2 warning signs

No single metric tells the full story. See the FRA:PHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Equasens Business Description

Address 5 Allee de Saint-Cloud, Technopole de Nancy Brabois, Villers-les-Nancy, FRA, 54600
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centers) and patients in both primary and secondary care sectors. The various activities that the company is involved in include: pharmacy software publishing and integration, publishing of IT solutions for health and medical/social establishments, and development of solutions and infrastructures for e-Health. With operations in France (its key revenue-generating market), Italy, Belgium, Germany, Ireland, and the United Kingdom, it is developing the healthcare platform and an ecosystem in France and Europe, benefiting people by making its technology services available.
93GF Score

Get the complete analysis for FRA:PHF

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€52.77
Price
€85.23
GF Value